Mar 13, 2023  |  4:00pm - 5:00pm
Monday seminar series

Molecular and Genetic Insight into AAA Disease (B. Lowell Langille Vascular Biology Lectureship)

Impactful research

As part of our Monday seminar series, and for the B. Lowell Langille Vascular Biology Lectureship, we are delighted to welcome our speaker:

Dr. Philip S. Tsao, PhD, FAHA
Associate Chief of Staff for Precision Medicine
VA Palo Alto Health Care System
Director, VA Palo Alto Epidemiology Research and Information Center (ERIC) for Genomics
Professor, Medicine (Cardiovascular Medicine) 
Stanford University School of Medicine

Hosted by

Dr. Jason Fish

How to join

The event will be in person only, no need to register.

MSB 2170

Medical Sciences Building
University of Toronto
1 King’s College Circle
Toronto, ON  M5S 1A8 

Details are sent to the LMP community in the Friday events bulletin.

If you have any questions about this event, please contact Louella D'Cunha at

Speaker: Dr. Philip S. Tsao

The primary goal of the Tsao laboratory is to elucidate the molecular mechanisms of vascular disease including atherosclerosis and abdominal aortic aneurysms.

My laboratory has primarily focused on signaling pathways and how they regulate vascular function and transcription. For this line of investigation, we utilize a variety of experimental approaches including molecular biology, cell biology, preclinical animal models, as well as translational clinical studies. Throughout these studies we have exploited high-density data quantification tools and have gained significant experience in the analysis of large data sets to elucidate relevant biological pathways in cardiovascular disease.  

Most recently, I have helped lead the VA’s Million Veteran Program as Co-PI where we have recently completed the largest single cohort genome-wide association studies investigating AAA, peripheral vascular disease, and coronary artery disease.  We believe that the intersection of preclinical mouse models and human genetics will help prioritize disease mechanisms for therapeutic target identification. 

Philip S. Tsao